An official website of the United States government
Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022
ORIGINAL RESEARCH — Volume 21 — June 20, 2024
PEER REVIEWED
Figure 1.
Preventive service usage among unique patients, National Patient-Centered Clinical Research Network (PCORnet) sites, 2018–2022. Percentages of patients receiving mammograms and Papanicolaou (Pap) tests or human papillomavirus (HPV) tests are presented out of all women receiving care that year from participating PCORnet sites; percentages of all other preventive services are presented out of all patients (men and women) receiving care that year from participating PCORnet sites. Colonoscopy indicates colonoscopy or sigmoidoscopy. Stool-based test indicates stool-based colorectal test. Total unique patient counts by year: 2018: N = 12,236,819 overall, 7,247,376 women; 2019: N = 13,026,666 overall, 7,695,294 women; 2020: N = 13,353,937 overall, 7,820,064 women; 2021: N = 15,590,610 overall, 9,127,882 women; 2022: N = 13,826,891 overall, 8,146,879 women.
| Preventive service | 2018, % | 2019, % | 2020, % | 2021, % | 2022, % |
|---|---|---|---|---|---|
| Wellness | 19.6 | 20.2 | 18.0 | 19.5 | 19.9 |
| Hemoglobin A1c | 18.1 | 19.3 | 18.7 | 20.5 | 22.4 |
| Lipid | 25.0 | 25.7 | 24.0 | 25.8 | 26.7 |
| Mammogram | 17.8 | 17.7 | 16.4 | 17.9 | 17.6 |
| Papanicolaou test or human papillomavirus test | 11.5 | 11.2 | 9.5 | 10.5 | 9.3 |
| Lung computed tomography | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 |
| Colonoscopy | 2.6 | 2.5 | 2.2 | 2.2 | 2.0 |
| Stool-based test | 1.6 | 1.8 | 1.6 | 1.8 | 2.3 |
Figure 2.
New chronic disease diagnoses among unique patients, National Patient-Centered Clinical Research Network (PCORnet) sites, 2018–2022. Percentages of patients newly diagnosed with breast cancer, cervical cancer, and cervical intraepithelial neoplasia or carcinoma in situ (CIN/CIS) are presented out of all women receiving care that year from participating PCORnet sites; percentages of patients diagnosed with all other conditions are presented out of all patients (men and women) receiving care that year from participating PCORnet sites. Cholesterol indicates initiation of a new cholesterol medication. Total unique patient counts by year: 2018: N = 12,262,754 overall, 7,264,953 women; 2019: N = 13,064,373 overall, 7,719,031 women; 2020: N = 13,402,584 overall, 7,849,336 women; 2021: N = 15,652,210 overall, 9,164,607 women; 2022: N = 15,506,288 overall, 9,128,281 women.
| Condition | 2018, % | 2019, % | 2020, % | 2021, % | 2022, % |
|---|---|---|---|---|---|
| Colonic adenoma | 1.06 | 1.03 | 0.85 | 0.97 | 1.10 |
| Cholesterol | 4.36 | 4.69 | 4.10 | 4.33 | 4.82 |
| Diabetes | 3.63 | 3.78 | 3.24 | 3.42 | 3.70 |
| Hypertension | 6.08 | 6.26 | 5.57 | 6.06 | 6.14 |
| Breast cancer | 0.47 | 0.47 | 0.43 | 0.44 | 0.46 |
| Lung cancer | 0.18 | 0.18 | 0.16 | 0.15 | 0.16 |
| Colorectal cancer | 0.14 | 0.14 | 0.13 | 0.13 | 0.14 |
| Cervical cancer | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 |
| CIN/CIS | 0.30 | 0.29 | 0.27 | 0.26 | 0.26 |
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.